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While studying the relationship between tumor growth and plasma enzyme 
activity, Riley a  a/.  (1) found a  transmissible  agent in the plasma  of many 
tumor-bearing mice which upon injection into normal mice produced a  five- 
to tenfold increase in the plasma activity of the  enzyme lactic dehydrogenase 
(LDH). The increase in plasma LDH occurred within 72 hours after injection 
of this lactic dehydrogenase elevating agent  (LDH agent)  and persisted for 
months despite the lack of gross pathology. In addition  to the enzyme LDH, 
Notkins  eta/.  (2)  found  that  isocitric dehydrogenase, malic dehydrogenase, 
phosphohexose  isomerase,  and  glutamic-oxalacetic  transamlnase  were  also 
elevated. Further studies  (2-4)  revealed that much  of the increased plasma 
enzyme activity which previously had been attributed to tumor growth was in 
fact  due  to  the  presence  of  this  agent.  Evidence from several  laboratories 
suggested that the LDH agent was a  virus  (5-9) and was being carried as a 
contaminant (5, 9) by a number of transplanted mouse tumors. However, most 
of the work reported thus far has been concerned with the relationship of this 
agent  to  the  tumor  and  plasma  enzymes.  Consequently there is  very little 
detailed information in the literature on the nature and properties of the agent 
itself. The studies reported herein describe some of these properties and the 
procedure used to assay the LDH agent.  The growth curve of this agent is 
described and findings pertaining to the incidence of cross-infection and trans- 
mission to offspring are presented. 
Materials and Methods 
LDH Agent.--Tho source and passage of the LDH agent has been described elsewhere 
(2). Two pools of infected plasma, designated P-9 and P-10, were obtained from mice 24 hours 
after they had been infected with the LDH agent. The infected plasma was put in individual 
vials, sealed under vacuum, and stored at --55°C until used. 
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Diluents.--Eagle's minimum essential medium  (10) with 20 per cent veal infusion broth 
(MEM-VIB)  1 was routinely used as the diluent for the LDH agent.  In other experiments 
0.1 ~  citrate-phosphate  buffer (citric acid  and  dibasic sodium phosphate)  at pH  4.0,  0.1 
phosphate buffer (monobasic potassium phosphate and dibasic sodium phosphate)  at pH 7.3, 
0.05 x¢ carbonate-bicarbonate buffer (anhydrous sodium carbonate and sodium bicarbonate) 
at pH 10.3, and Dulbecco's phosphate-buffered saline (PBS) (11) with calcium and magnesium 
were used as diluents. 
Plasma  for Enzyme Assay.--Blood was obtained by orbital bleeding with heparinized micro- 
pipettes (12). Plasma was separated from the cells by centrffugation at 1500 G for 15 minutes 
and kept at 4°C until assayed. Hemolyzed specimens were not used. 
Lactic Dekydrogenase En,yme  Assay.--The  enzyme  lactic  dehydrogenase  was  assayed 
according to the method of Wroblewski and LaDue (13).  One unit of enzyme activity is de- 
fined as the amount of enzyme which produces a decrease of 0.001 per 1 minute in the optical 
density of reduced nicotinamide-adenine dinueieofide  (NADH2) at 340  m/z. 
Animals.---CAF-1 male mice, 4 to 6 weeks old and bred at the Animal Production Section 
of the National Institutes of Health, Bethesda, were used throughout the experiments. 
Detection and Titration of the LDlt Agent.--72 to 96 hours after injection of the LDH agent 
mice were bled and the units of enzyme (LDH) per milliliter of plasma were determined. In- 
fected mice showed a five- to tenfold increase in plasma LDH while the  plasma  LDH from 
uninfected mice remained within the normal range. This five- to tenfold increase in enzyme 
activity served as the basis for detecting the LDH agent. Most enzyme determinations were 
done 72 to 96 hours after injection of the agent, but since the plasma LDH activity of infected 
mice was still elevated at the end of 1 year assays could be performed weeks and even months 
later. Specimens showing hemolysis were not used. Animals from which these specimens were 
obtained were simply bled again several days later. If doubt remained as to whether a particu- 
lar animal was infected, the question was resolved by injecting its plasma into a normal mouse 
and then testing the latter for the characteristic increase in plasma LDH activity. 
The infective fiter of the LDIt agent in a  given preparation was determined by mnk~ng 
serial tenfold dilutions. Except where indicated, Eagle's MEM-VIB was used as the diluent. 
Five mice served as recipients for each dilution and received 0.1  ml intraperitoneally. These 
animals were bled 72 to 96 hours later and tested for the five- to tenfold increase in plasma 
LDH activity. The number of animals infected at each dilution was determined and the IDs0/ 
ml (dose that infected 50 per cent of the animals) was calculated by the method of Reed and 
Mnench (14) and expressed on the basis of 1.0 ml of material. 
RESULTS 
Reproducibility  of Assay  Used for the  Titration  of the  LDtt Agent.--To  de- 
termine the reproducibility of the assay, five completely separate sets of serial 
tenfold  dilutions  were made  from  a  single lot  of virus.  PBS  was  used  as  the 
diluent  in  three  of the  assays  and  Eagle's MEM-VIB  was  used  for the  other 
two. As seen in Table I, the titer of the agent varied from 108.7 to 109.5 IDs0/ml 
with four out of the five values falling between 108.7 and  109.3 IDs0/ml. 
Stability of LDH Agent.--The stability of the LDH  agent was determined by 
storage  in  individual  vacuum  sealed  vials at  --55°C  for  6  weeks.  As  seen  in 
Table I, there was no appreciable loss of activity at the end of that  time. 
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TABLE I 
Reproducibility of the Assay Used to Determine the Infective Titer of the LDH Agent 
IDio/ml  Material  tested  Diluent  Assay No.  (log  1o) 
PBS*  Stock  preparation  of LDH  agent 
(P-9) 
Stock  preparation  of LDH  agent 
(P-9) stored at -55°C for 6 wks. 
Eagle's MEM-VIB$ 
PBS 
Eagle's MEM-VIB 
8.7 
8.7 
9.5 
9.2 
9.0 
8.6 
8.7 
* Dulbecco's phosphate-buffered saline. 
~: Eagle's minimum essential medium with 20 per cent veal infusion broth. 
Effect of Dose of the LDH Agent on Plasma Enzyme Activity 
To study the effect of different doses of the LDH agent on plasma enzyme activity, prepa- 
rations containing 101"5, 104"5, and 10  v-5 ID60/ml were prepared in Eagle's MEM-VIB. Each 
mouse received 0.1 ml intraperitoneally of one of the above preparations and ten animals were 
used in each group. Control mice received 0.1 ml of diluent intraperitoneally.  At 24, 48, 72, 
and 96 hours after injection the plasma LDH activity of each animal was determined. The 
individual LDH values were averaged and the standard deviation was calculated. 
As indicated in Table II, all infected groups showed an increase in plasma 
enzyme activity over 96 hours. However, the mean plasma LDH level of those 
animals which received 101'5 ID60/ml was considerably lower at 48 hours than 
TABLE II 
Rdationship of Dose of the LDtt Agent to Plasma Enzyme Activity 
Virus dose injected,* ID~o 
Controls 
101.6 
104.6 
107.6 
Enzyme activity--units LDH/ml plasma~ 
Hrs. after injection 
24  48  72  96 
290 4- 165§ 
278  4-  164 
325  4-  121 
890  4-  106 
4664-81 
1740 4- 363 
2590 4- 426 
3240 4- 494 
341  4-  134 
3760 4- 328 
4215 4- 504 
4310 4- 475 
480  4-  126 
4994 4- 408 
4905 4-  348 
5375 4-  569 
* Injected intraperitoneaUy. 
:~ Each figure represents the average of 10 mice. 
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the mean of those which had received  107.5 IDso/ml. At 96 hours  the plasma 
LDH  activity  of the  three  groups  was  approximately  the  same.  Thus,  the 
higher the infective dose, the more rapid the initial increase in plasma enzyme 
activity. 
Growth Curve 
Donor mice were injected intraperitoneally with 10 5.9 IDs0 of theLDH agent. At intervals 
thereafter,  the donors were bled in groups of five. Exactly 50 #1 of plasma from each of the 
five donors was pooled and 0.2 ml of this pool was added to 1.8 mi of Eagle's MEM-VIB to 
make a 10  -1 dilution. Serial tenfold dilutions were continued in Eagle's MEM-VIB and 0.1 
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Fro. 1. Growth curve of the LDH agent and changes in the plasma activity of the enzyme 
LDH. 
ml of each appropriate  dilution was injected intraperitoneally  into recipient mice. 72 to 96 
hours later these recipients were bled and the plasma was assayed for enzyme activity (units 
LDH/milliliter).  The number of animals infected was determined and the ID.0 of the donor 
plasma was calculated. 
As seen in Fig. 1, the injected virus was recovered from the plasma of donor 
mice within 5 minutes after intraperitoneal  injection. At 6 hours the infective 
titer in the plasma was 10  e.6 ID60/ml, indicating that multiplication of the LDH 
agent had taken place (since the titer per milliliter of donor plasma was higher 
than the initial inoculum). The titer of the LDH agent then steadily increased, 
reaching  101°.8 IDs0/ml  within  24 hours.  Over the  next  72  hours  the  plasma 
titer  fell  3  logarithms  to  10  v.s but  decreased  only  1  additional  logarithm  to ABNER LOUIS NOTKINS AND  STEPHEN J.  SHOCHAT  739 
10. .7 by the end of the 3rd week. At 10, 12, and  16 months the titers were 10  *'4, 
104.3, and 105.2 IDs0/ml respectively. 
The enzyme activity of donor plasma was determined on the same samples 
used  to  titrate  the LDH  agent.  Each  point  on  the  enzyme  curve  in  Fig.  1 
represents  the  average  of individual determinations from  five mice.  The  in- 
crease in plasma enzyme activity lagged 18 to 24 hours behind virus multiplica- 
tion. At 24 hours when the virus titer was at its peak, plasma enzyme activity 
was only slightly above normal. At 96 hours when the plasma enzyme activity 
had reached its highest point, the titer of the LDH  agent had fallen by 3 log- 
arithms. At 10 months when the infective titer of the LDH agent had decreased 
by 6 logarithms, the plasma LDH  activity had decreased by only 50 per cent. 
Properties of the LDH Agent 
Free~.ing and thawing. 
A stock preparation of the LDH agent was diluted 10  --2 in PBS, frozen in dry ice and ace- 
tone, and then thawed at 37°C. This procedure was carried out five times within a 20 minute 
period. Serial tenfold dilutions were made in PBS and the infective titer was determined. 
As seen in Table HI, freezing and thawing five times produced  a decrease in 
the infective titer in only one out of the three experiments. 
TABLE HI 
Effect of Freezing and Thawing, Lyophilization, and Ether on the Infective Titer of ~he 
LDH Agent 
Treatment  IDso/ml (log 10) 
Stock preparation of LDH agent ....................... 
Freezing and thawing* ................................ 
Lyophi|i~ation 
Stored at 4°C for 4 days  ............................. 
Stored at 4°C for 90 days  ............................ 
Stored at 22°C for 17 days  ........................... 
Stored at 22°C for 90 days  ........................... 
Ether 
15 per cent at 4°C for 24 hrs  .......................... 
15 per cent at 4°C for 15 rain  ......................... 
8.9 
8.6 
7.5 
8.5 
8.6 
8.5 
9.2 
7.7 
* Values from three separate experiments. 
L yophiUzation. 
A stock preparation of the LDH agent was diluted 10  -* in Eagle's MEM-VIB. 1 ml was 
placed in individual vials, frozen in dry ice and acetone, and lyophilized overnight. The vials 740  LACTIC  DEHYDROGENASE  AGENT 
were sealed under vacuum and stored in the dark at either 4°C or 22°C.  At various times 
thereafter, vials were opened and reconstituted to the original volume with distilled water. 
Serial tenfold dilutions were made in Eagle's MEM-VIB and the infective titers were de- 
termined. 
As seen in Table III, lyophilization and storage at 4°C for as long as 90 days 
did not alter the infective titer. However, storage at 22°C for 90 days did result 
in some loss  of activity. 
Treatment witk ether. 
To a  preparation of the LDH agent containing  106.9 ID~0/ml in  Eagle's MEM-VIB, 15 
per cent anesthetic ether  (MalUnckrodt Chemical Works,  St.  Louis)  was  added.  The test 
tube was stoppered, shaken, and kept at 4°C for 24 hours. Nitrogen was then bubbled through 
the tube to remove the ether. A control tube, unexposed to ether, was handled similarly. 
As seen in Table III, intraperitoneal injection of 0.1 ml of the ether-treated 
material into recipient mice failed to produce infection. Further experiments 
revealed that treatment with 15 per cent ether for as little as  15 minutes at 
4°C resulted in complete loss of infectivity if that material was shaken vigor- 
ously several times during the incubation period. If however, the ether was 
simply layered  over  the  surface  of  the  aqueous  material  without  shaking, 
infectivity was not lost at the end of 15 minutes. 
Effect of temperature. 
A preparation of the LDH agent was diluted 10  -2 in PBS and was incubated at 4°C, 22°C, 
and 37°C for 24 hours; 60°C and 80°C for 30 minutes; and 100°C for 2 minutes. After incuba- 
tion, serial tenfold dilutions were made in PBS and the infective titer of each preparation was 
determined. 
TABLE  IV 
Eff~t~ Temperatureontheln/~t~eTit~ ~theLDH Ag~t 
Temperature 
Stock§ 
4°C 
22°C 
37°C 
60°C 
80°C 
100°C 
Incubation  time 
0 
24 hrs. 
24 hrs. 
24 hrs. 
30 min. 
30 min. 
2 rain. 
ID~o/ml  (log  ~o) 
Experiment I* 
8.9 
9.0 
9.0 
7.7 
0 
0 
Experiment 2t 
10.5 
9.8 
9.5 
7.8 
3.5 
0 
0 
* Stock preparation P-9 was used. 
Stock preparation P-10 was used. 
§ The stock preparations were diluted 10  -2 in phosphate-buffered saline prior to incubation. ABNER  LOUIS  NOTKINS  AND  STEPHEN  J.  SHOCHAT  741 
As seen in Table IV the LDH agent was stable at 4°C for 24 hours but was 
partially inactivated at 37°C for 24 hours. Almost total loss of activity occurred 
at 60°C for 30 minutes and complete inactivation took place at 80°C for 30 
minutes and  100°C for 2 minutes. 
Effect of diluents. 
To compare the effect of different diluents on the infective titer of the LDH agent, a stock 
preparation was diluted 10  -2 in Eagle's MEM-VIB, PBS, distilled water, phosphate, citrate- 
phosphate, and carbonate-bicarbonate buffers. These preparations were allowed to stand at 
4°C for 3 hours and then serial tenfold dilutions were made with the original diluent. 
TABLE V 
Infective Titer of the LDH Agent After Incubation at 4°C for 3 Hours in Different Diluents 
Diluent* 
Eagle's MEM-VIB§ 
Distilled water [l 
PBS¶ 
Carbonate-bicarbonate buffer 
Phosphate buffer 
Citrate-phosphate buffer 
pH:~ 
7.3 
6.6 
7.3 
10.3 
7.3 
4.0 
IDio/ml (log  xo) 
Experiment 1  Experiment  2 
10.5  10.4 
--  10.4 
--  9.7 
9.3  9.4 
8.8  8.5 
7.6  7.6 
* A stock preparation of the LDH agent was diluted 10  "~ in each diluent and incubated 
at 4°C for 3 hours. The infective titer was determined by using the same diluent to do serial 
tenfold dilutions (except distilled water). 
pH measurements were made on the diluents after the LDH agent had been added. 
§ Eagle's minimum essential medium with 20 per cent veal infusion broth. 
]] Mter incubation in distilled water,  the serial tenfold dilutions were  made in  Eagle's 
MEM-VIB. 
¶ Dulbecco's phosphate-buffered saline. 
As seen in Table V, the highest titer was obtained when the LDH agent was 
diluted  in  Eagle's  MEM-VIB.  Substantially  lower  titers  were  found  with 
phosphate and citrate-phosphate buffers. 
Sedimentation of the LDH agent. 
Modification of the procedure  described by Moloney to  concentrate virus from plasma 
was employed to sediment the LDH agent (15). 24 hours after intraperitoneal injection of the 
LDH  agent,  mice were  anesthetized and heparinized blood was  obtained from the axilla. 
Plasma was separated from the cells by centrifugation  at  1500  G for  20  minutes, diluted 
with 0.3 M potassium citrate containing 3.0 mg per cent hyaluronidase, and was centrifuged 
at 2500 G for 15 minutes  and  at  10,000  G  for 2 minutes. The infective titer of  the LDH 
agent in the plasma was  then  determined  and  the  final centrifugation was performed at 742  LACTIC DEttYDROGENASE AGENT 
105,000 G for 2 hours in a Spinco model L Ultracentrifuge with a  40 rotor. 1 ml of the re- 
stilting supematant fluid was withdrawn by inserting a  26 gauge needle  through the side of 
the cellulose centrifuge tube at a point one-third of the distance from  the top and  the in- 
fective titer was determined. The remainder of the supematant fluid was poured off and the 
tube drained. A pellet about 1.0 mm in diameter was seen and resuspended  to the original 
volume. The infective  titer of the resuspended  pellet was determined. 
As seen in Table  VI,  most  of the virus was  recovered in  the resuspended 
pellet. Less than 0.1 per cent of the LDH  agent remained in the supernatant 
fluid. 
TABLE VI 
Sedimentation of the LDH Agent 
Materials assayed  for infectivity*  ID60/ml (log  ao) 
Before ultracentrifugation 
Infected plasma 
After uitracentrifugation 
Resuspended  pellet 
Supematant fluid 
10.5 
9.8 
6.6 
* The infected plasma containing 10  t°.5 ID~o/ml was centrifuged at  105,000 G for 2 hours 
An aliquot of the supernatant fluid was removed  and  assayed for infectivity. The virus 
pellet was then resuspended to the original volume and assayed for infectivity. 
Estimation of size of the LDH agent. 
In cooperation with Dr. Wallace Rowe of the National Institute of Allergy and Infectious 
Diseases, gradocol membrane studies were performed.  Infected plasma titering about 10  e'° 
ID60/ml was diluted 10  -2 in Eagle's MEM-VIB, centrifuged  at 1500 G for 20 minutes, and 
then passed through an 800 m/~ Millipore filter. Aliquots of the Mlllipore filtrate were passed 
through gradocol membranes of 320, 140, 110, and 74 m# pore size. The gradocol membrane 
filtrates were tested for infectivity. The materials which had passed through the 320, 140, and 
110 m# membranes all infected mice, but that which was filtered through the 74 m# membrane 
failed to infect mice. 
Because of factors such as clogging of the pores and adsorption to the mem- 
brane, determination of particle size by this procedure is at best a  rough ap- 
proximation. According to Elford (16)  the size range of a  virus is one-third to 
one-half of the smallest pore size through  which  it passes. On  this basis the 
maximum size of the LDH  agent would be 55 m~. However, if the correction 
factor suggested by Markham  (17)  is used,  the size of the particle would be 
somewhat larger. A  separate isolate of the LDH  agent, obtained by Dr. Rowe 
in his laboratory, passed through a  110 m~ membrane, partially passed through 
an  85  m~  membrane,  but  failed  to pass  a  75  m/z  membrane  (18).  Electron 
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Transmission  of the LDH Agen~ 
Transmission to cagema~. 
Because of the association of the LDH agent with over 40 different types of mouse tumom 
(1, 5, 7-9) it was of interest to see if this agent would spread from infected to uninfected mice 
kept in the same cage. Five mice were placed in es~h cage and injected with the LDH agent. 
An equal number of normal (imlnjeeted) mice were iromediately placed in the same cage. All 
animals were numbered and at appropriate  intervals thereafter,  both injected and uninjected 
mice were bled and the number of newly infected animals was determined. 
In the first experiment  (Table VII) none of the normal mice had become 
infected within  the first 45  days and only 2  were infected at  120 days.  (The 
late infection of these two mice raises the possibility that accidental contamina- 
tion of the blood collecting pipettes  during one of the earlier bleedings might 
TABLE VII 
Transmission of the LDH Agent to Cagema~ 
After injection  Experiment I*  Experiment 2 
da~ 
3 
17 
3O 
45 
75 
120 
0•20 
0/2O 
0/20 
2/20 
1/20 
1/2o 
* On day zero, 20 mice were infected with the LDH agent. An equal  number of normal 
(lmlnfected) mice were placed in the same cages. At intervals thereafter the normal cagemates 
were examined for infection. The figures represent the number of newly infected mice/original 
number of uninfected mice. 
have resulted  in orbital  inoculation of the LDH  agent and infection).  In the 
second experiment only one out of twenty normal mice became infected. 
Since less than  10 per cent of the animals had become infected, it was im- 
portant  to  determine  whether  the  remaining  uninfected  animals  were  still 
susceptible to the LDH agent or whether they had developed resistance to the 
agent as a result of prolonged exposure to the infected mice. A plasma pool was 
obtained  from the  infected  mice,  diluted  10  -1 in Eagle's MEM-VIB  and  in- 
jected intraperitoneaily into the uninfected mice of the same cage. All of these 
animals  became  infected  within  72  hours.  Although  the  incidence  of  cross- 
infection by ordinary contact  was relatively low,  the  mice were readily sus- 
ceptible to the LDH agent by the parenteral route. 744  LACTIC DEHYDROGENASE AGENT 
Transmission to offspring. 
Five adult male and five adult female mice were injected intraperitoneally with a prepara- 
tion of the LDH agent containing 10 5.9 IDs0. 1 week later these animals were mated and the 
females were placed in separate cages.  Approximately 1 month after birth the number of 
offspring infected was determined. 
As seen in Table VIII, only one out of the forty offspring became infected. 
However,  experiments  in progress indicate that inoculation of mice with the 
LDH agent during pregnancy (rather than prior  to pregnancy) leads  to an 
extremely high per cent of infected offspring. These studies  will be reported 
separately. 
TABLE VIII 
Transmission of the LDH Agent to Offspring/tom Mothers Infected Prior to Pregnancy* 
Litter No.  No. mice infected/total mice  per litter 
o/7 
017 
1/7 
O/9 
o/lo 
* Both parents were infected with the LDH agent prior to mating. Offspring were exam- 
ined for infection approximately 1 month after birth. 
DISCUSSION 
In studying the relationship between virus multiplication and plasma enzyme 
activity it was noted that at the height of viremia (10  l°.s IDs0/ml) the plasma 
LDH activity had increased by less than twofold. At 96 hours when the plasma 
LDH activity was at its height (ten-  to twelvefold above normal), the virus 
titer had already decreased by more than one thousandfold. Thus, the appear- 
ance of virus in the circulation preceded the increase in plasma LDH activity. 
However,  because of such factors as the rate of release of an enzyme from a 
cell and the kinetics of clearance of enzymes from the plasma, it is difficult to 
evaluate critically the significance of this time-lag or to determine the exact 
relationship  between  virus  multiplication and  the increase  in plasma LDH 
activity. The mechanism  by which the LDH agent produces  the increase in 
plasma enzyme activity still remains obscure, but it has been suggested (2, 4) 
that the LDH agent may act by stimulating cellular enzyme production or 
producing  cell damage and subsequent  release of enzyme into the circulation. 
Although it is not unreasonable  to postulate that the enzyme may be released 
from the same  cell as  that in which  the virus grows, another possibility  is 
suggested by the above data. Virus or viral by-products may enter the circula- ABNER LOUIS NOTKINS AND STEPHEN J.  SHOCHAT  745 ¸ 
tion and act upon or damage a second cell (target cell) from which the enzyme 
is actually released. If the number of these target cells were few as compared 
to the number of virus particles,  a low titer of virus might completely saturate 
these cells and produce a maximal rise in plasma enzyme activity. The excess 
virus  particles  over  the  saturation  number  would  not  lead  to  any 
further increase in plasma LDH activity. This explanation could account for 
the less than 50 per cent decrease in plasma enzyme activity at 10 months, 
although the titer of the LDH agent had dropped by over one millionfold. This 
could also explain  the relatively constant plasma enzyme elevation (five- to 
twelvefold  above  normal)  following  infection  as  compared  to  the  marked 
changes in virus titer. 
The plasma titer of the LDH agent reached  1@  °'s ID6o/mi within 24 hours 
after infection,  but fell to 104"s ID~0/mi by the end of 3 months. The plasma 
titer remained at approximately that level for the next 13 months. A persistent 
viremia of this duration is unusual and suggests that the host does not have a 
completely adequate defense against the LDH agent. 
Recent studies in our laboratory showed that the LDH agent was present in 
the saliva,  urine, and feces of infected mice  (19). The titer  as compared  to 
plasma was relatively low and virus was recovered  only early in the course of 
infection. In addition, it was possible to infect mice by the oral route, but only 
if a high concentration of the LDH agent was used. The spread  of the LDH 
agent from infected to uninfected mice housed in the same cages was low (Table 
VII). This low incidence of infection by ordinary contact and the failure thus 
far to find the LDH agent in normal mice suggests that the serial parenteral 
administration of contaminated biological materials, such as plasma,  organs, 
or tumors from infected animals, may be the major factor responsible for the 
persistence of this agent in the laboratory setting. 
The high plasma titer, the persistent viremia, the rapid and prolonged eleva- 
tion of a number of plasma enzymes, and the lack of gross pathology add to the 
list of unusual properties  which are displayed by the LDH agent in mice. 
SUMMARY 
The procedure  used to determine the infective titer of the LDH agent, the 
reproducibility of this  assay, and  the  relationship  between  virus  dose  and 
plasma  enzyme activity were  described.  Multiplication of  the  LDH agent 
began within 6 hours after infection and reached 101°.8 IDs0/ml of plasma with- 
in 24 hours.  The titer rapidly decreased  over the next 72 hours but viremia 
persisted  for at least 16 months with titers as high as I06.2 ID~0/ml. The ap- 
pearance of the LDH agent in the circulation preceded the first noticeable rise 
in plasma LDH activity  by close to 24 hours. After l0 months, when the plasma 
titer  of the LDH agent  had  decreased  nearly one  millionfold,  the  plasma 
enzyme LDH had decreased by less than 50 per cent. 746  LAC~C  DEHYDROGENASE  AGENT 
The LDH agent is inactivated by ether but withstands lyophilization, and 
freezing and thawing. It is stable at low temperatures. Ultracentrifugation at 
105,000  G for 2 hours leaves less than 0.1  per cent of the LDH agent in the 
supernatant fluid and filtration through gradocol membranes suggesst that the 
upper size of the LDH agent is about 55 m#. 
Spread of the LDH agent from infected to uninfected mice kept in the same 
cage and transmission from mothers (infected prior to mating) to their offspring 
was relatively low. 
The authors wish to thank Dr. Henry Scherp, Dr. John Moloney, Dr. Mark Woods, and 
Dr. Charles Wittenberger for their many helpful suggestions in preparing the manuscript and 
Miss Christina Scheele  for her technical assistance. 
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